Search research articles
Contact Us
Filters
Showing results (161-170 of 172) with videos related to
Page
of 18
Sort By:
Plant, Cell & Environment
|
January 29, 2024
The AP2/ERF transcription factor MdDREB2A regulates nitrogen utilisation and sucrose transport under drought stress
Ting-Ting Zhang, Yu-Jing Lin, Hao-Feng Liu, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2021
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers
Xu Yang, Ying Hu, Keyan Yang, et al.
Journal of Hepatocellular Carcinoma
|
March 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Xiaokun Chen, Xiangan Wu, Wei Peng, et al.
Neoplasma
|
January 24, 2022
Prognostic value of circulating tumor cells and its association with the expression of cancer stem cells in nasopharyngeal carcinoma patients
Lin Lu, Hao-Wei Huang, Huan Du, et al.
Hepatobiliary Surgery and Nutrition
|
August 25, 2020
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma
Jianzhen Lin, Xu Yang, Junyu Long, et al.
Journal of Gastrointestinal Oncology
|
September 12, 2022
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)
Xiang Wang, Diansheng Zhong, Junping Zhang, et al.
Theranostics
|
March 23, 2021
Mutational spectrum and precision oncology for biliary tract carcinoma
Jianzhen Lin, Yinghao Cao, Xu Yang, et al.
Hepatology International
|
February 8, 2023
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
Xu Yang, Bowen Chen, Yanyu Wang, et al.
BMC Medicine
|
January 28, 2024
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Xu Yang, Baofeng Lian, Nan Zhang, et al.
The Plant Journal : for Cell and Molecular Biology
|
August 30, 2017
The high-quality genome of Brassica napus cultivar 'ZS11' reveals the introgression history in semi-winter morphotype
Fengming Sun, Guangyi Fan, Qiong Hu, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 172) with videos related to
Sort By:
Page
of 18
Plant, Cell & Environment
|
January 29, 2024
The AP2/ERF transcription factor MdDREB2A regulates nitrogen utilisation and sucrose transport under drought stress
Ting-Ting Zhang, Yu-Jing Lin, Hao-Feng Liu, et al.
Journal for Immunotherapy of Cancer
|
May 11, 2021
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers
Xu Yang, Ying Hu, Keyan Yang, et al.
Journal of Hepatocellular Carcinoma
|
March 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Xiaokun Chen, Xiangan Wu, Wei Peng, et al.
Neoplasma
|
January 24, 2022
Prognostic value of circulating tumor cells and its association with the expression of cancer stem cells in nasopharyngeal carcinoma patients
Lin Lu, Hao-Wei Huang, Huan Du, et al.
Hepatobiliary Surgery and Nutrition
|
August 25, 2020
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma
Jianzhen Lin, Xu Yang, Junyu Long, et al.
Journal of Gastrointestinal Oncology
|
September 12, 2022
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)
Xiang Wang, Diansheng Zhong, Junping Zhang, et al.
Theranostics
|
March 23, 2021
Mutational spectrum and precision oncology for biliary tract carcinoma
Jianzhen Lin, Yinghao Cao, Xu Yang, et al.
Hepatology International
|
February 8, 2023
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
Xu Yang, Bowen Chen, Yanyu Wang, et al.
BMC Medicine
|
January 28, 2024
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Xu Yang, Baofeng Lian, Nan Zhang, et al.
The Plant Journal : for Cell and Molecular Biology
|
August 30, 2017
The high-quality genome of Brassica napus cultivar 'ZS11' reveals the introgression history in semi-winter morphotype
Fengming Sun, Guangyi Fan, Qiong Hu, et al.
Page
of 18